Updates

ICYMI: In anticipation of today’s Cures markup, E&C releases an updated draft while Pew launches a new Rx initiative

May 14, 2015

May 14, 2015 The House Energy and Commerce Committee released an updated Read More

Press Release: New Trend Report Confirms Drug Prices On Unsustainable Path

May 13, 2015

May 13, 2015 New Drug Report Reveals Drug Costs Top $50,000/year for Over Half Read More

ICYMI: FDA Advisory Panel Approves New Cystic-Fibrosis Drug while Americans Continue to Pay the Price of High Cost Drugs

May 13, 2015

May 13, 2015 The New York Times: “Cystic Fibrosis Drug Wins Approval of Read More

ICYMI: “As E&C Prepares Cures Bill Markup, Negative Press On Drug Prices On The Increase”

May 12, 2015

May 12, 2015 InsideHealthPolicy.com Health Reform Insider: “As E&C Read More

ICYMI: Vertex’s Cystic-Fibrosis Drug Could Come at a Cost

May 11, 2015

May 11, 2015 The Wall Street Journal: “Vertex’s Cystic-Fibrosis Read More

Weekly Update – How much is too much?

May 8, 2015

Weekly Update – 5/8/2015 We learned this week that worldwide spending on Read More

ICYMI: Should the Specialty Drug Cost Debate Take a Breath? Data Proves Otherwise.

May 7, 2015

ICYMI: May 7, 2015 PharmaExec.com: “Take a Breath” on the Specialty Drug Read More

ICYMI: Washington’s Role in High Drug Costs — Marketing Exclusivity and “Shadow Pricing”

May 6, 2015

ICYMI: May 6, 2015 National Journal: Washington’s Interest in Precision Read More

ICYMI – Where’s Robert Stack When You Need Him?

May 5, 2015

ICYMI May 5, 2015  The New York Times: Runaway Drug Prices How companies set Read More

ICYMI: High Drug Costs Impact Wall Street and Spark a New Initiative in the White House

Apr 28, 2015

April 28, 2015 Note: Distributing the New York Times article below is not an Read More

ICYMI: Two WSJ Articles Highlight High Drug Prices

Apr 27, 2015

Two-fer ICYMI: Two WSJ Articles Highlight High Drug Read More